NCT06114914
Who may be able to join
Who might be able to join this trial:
For the first two parts of the study (Aims 1 & 2):
- You are over 50 years old and already taking part in the ISLAND Project
- You have already given a blood sample as part of the ISLAND Project
- You currently have normal memory and thinking skills and have not had any ongoing thinking or memory problems lasting more than 3 months
For the third part of the study (Aim 3):
- You are over 50 years old
- You or a family member have noticed ongoing memory or thinking difficulties that have lasted more than 3 months
Who may not be able to join:
For the first two parts of the study (Aims 1 & 2):
- You have shown signs of significant memory or thinking difficulties on a specific computer-based memory test used in this study (confirm with trial site)
For the third part of the study (Aim 3):
- You are currently seriously unwell
- You have significant difficulty using your hands (which may affect computer-based testing)
- You have already been diagnosed with mild cognitive impairment (early memory problems) or dementia
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Classification accuracy for blood biomarker of Alzheimer's disease, ptau181 in adults without cognitive symptoms; Odds ratio of cognitive decline in adults without cognitive symptoms; Classification accuracy for prospectively predicting risk of MCI and AD in adults with cognitive symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.